Avalon Ventures is an early stage venture capital fund focused on information technology and life sciences.
Business Model:
Revenue: $6.7M
Employees: 2-10
Address: 1134 Kline Street
City: La Jolla
State: CA
Zip: 92037
Country: US
Avalon’s long-standing and successful focus has been on seed and early stage companies, including many it formed in the life science and information technology sectors. We believe this is the most challenging and rewarding period of company creation – we are former entrepreneurs driven by passionate people pursuing disruptive ideas in ever changing market environments.
Contact Phone:
+18583482180
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2013 | LoopIt | Seed Round | - |
4/2018 | Synthorx | Series C | 63M |
2/2011 | Kaltura | Series C | 20M |
6/2008 | Kaltura | Series B | 21M |
4/2003 | Ansata Therapeutics | Series B | 2.5M |
6/2015 | Ankasa Regenerative Therapeutics | Series A | 8.5M |
4/2020 | Figg | Funding Round | - |
11/2007 | BioVex | Series E | 35M |
10/2003 | BioVex | Series C | 28.4M |
10/2014 | StackIQ | Series B | 6M |
7/2014 | ScoreStream | Convertible Note | 800k |
2/1992 | Metra Biosystems | Venture Round | - |
5/2009 | E-Band Communications | Series C | - |
7/2006 | AnaptysBio | Series A | 2M |
9/2011 | RethinkDB | Series A | 0 |
9/2014 | Sidecar Technologies | Series C | 15M |
10/2012 | Proximal Data | Series A | 3M |
12/2015 | AlphaSheets | Seed Round | 5.5M |
2/2014 | Empyr | Series B | 10.5M |
5/2013 | Happy Cloud | Series A | 4.3M |
12/2010 | Cloudant | Series A | 1M |
6/2006 | Kalon Semiconductor | Series A | 10.9M |
7/2012 | Backupify | Series C | 9M |
2/2012 | Memrise | Seed Round | 0 |
6/2021 | Primer | Series C | 0 |
11/2014 | Redbooth | Series B | 11M |
9/2011 | Backupify | Series B | 5M |
6/2012 | Cardeas Pharma | Series A | 8.5M |
3/2017 | Smyte | Series A | 4M |
2/2013 | Simulmedia | Series C | 5M |
1/2015 | Primer | Seed Round | - |
1/2014 | Quippi | Venture Round | 2M |
11/2012 | Pingup | Series A | 4M |
6/2015 | Calporta Therapeutics | Series A | 10M |
12/2012 | Cheezburger | Venture Round | 5M |
1/2011 | Cheezburger | Venture Round | 30M |
5/2007 | Kaltura | Series A | 2.1M |
12/2000 | Ambit Biosciences | Series B | 18.8M |
2/2000 | ChoiceSeat technology | Venture Round | 22.4M |
11/2006 | Amira Pharmaceuticals | Series A | 4M |
7/2007 | Awarepoint | Series B | 2M |
3/2018 | Averon | Series A | 11.7M |
10/2017 | Averon | Series A | 8.3M |
3/2020 | AristaMD | Series B | 0 |
1/2010 | Pictela | Venture Round | 1.5M |
10/2011 | Chartio | Series A | 3.1M |
10/2018 | Seva Inc. | Seed Round | 2.4M |
7/2011 | Shelby.tv | Seed Round | 1.5M |
9/2014 | Kinvey | Series B | 10.9M |
6/2012 | Awarepoint | Venture Round | 14M |
11/2011 | Standing Cloud | Venture Round | 3M |
12/2008 | Awarepoint | Series D | 13.3M |
5/2005 | Ambit Biosciences | Series C | 31M |
2/2016 | Orion Labs | Series A | 9M |
5/2014 | BookBub | Series A | 3.8M |
6/2010 | Otonomy | Series A | 10M |
4/2010 | Cloudkick | Series A | 2M |
10/2012 | Selectable Media | Series A | 2M |
8/2011 | Nanigans | Series A | 3M |
1/2015 | StackRox | Seed Round | - |
3/2014 | Indix | Series A | 8.5M |
11/2008 | Selectable Media | Venture Round | 2.6M |
11/2010 | Standing Cloud | Series B | 3M |
10/2007 | Awarepoint | Series C | 3M |
3/2006 | Awarepoint | Series A | 4M |
9/2014 | Avelas Biosciences | Series B | 7.4M |
1/2014 | Avelas Biosciences | Series B | 6.8M |
3/2011 | Tapad | Angel Round | 0 |
1/2009 | Pictela | Series A | 1.3M |
11/2017 | ScoreStream | Series A | 0 |
7/2012 | Shelby.tv | Series A | 2.2M |
11/2006 | Vocera Communications | Series F | 7M |
10/2004 | Vocera Communications | Venture Round | 6M |
2/2005 | Cambrios Technologies | Series B | 12M |
4/2007 | Cambrios Technologies | Series C | 18.5M |
11/2009 | Cambrios Technologies | Series D | 14.5M |
12/2011 | Cloudant | Venture Round | 2.1M |
12/2013 | Simulmedia | Series D | 25M |
4/2013 | Indix | Series A | 6M |
7/2015 | AeroFS | Series B | 10M |
1/2015 | Primer | Venture Round | - |
8/2015 | Skycatch | Series B | 0 |
10/2014 | Empyr | Venture Round | 11M |
9/2013 | Otonomy | Series C | 45.9M |
8/2015 | MOGL | Venture Round | 7.9M |
3/2021 | Janux Therapeutics | Series A | 0 |
10/2014 | MOGL | Venture Round | 11M |
8/2016 | Avelas Biosciences | Series C | 0 |
4/2015 | Cardeas Pharma | Series B | 37.5M |
6/2015 | Pronoun | Series B | 3.5M |
10/2011 | TwinStrata | Series B | 8M |
5/2015 | Tapad | Series B | 0 |
9/2008 | Afraxis | Series A | 1.5M |
7/2012 | Byliner | Series A | - |
4/2013 | Proximal Data | Series B | 2M |
6/2010 | Chartio | Seed Round | 0 |
6/2020 | Pando | Series A | 0 |
12/2017 | Pando | Seed Round | 3.1M |
8/2021 | Jnana Therapeutics | Series B | 50M |
5/2014 | Skycatch | Venture Round | 13.2M |
9/2014 | Thyritope Biosciences | Series A | 10M |
6/2017 | Talla | Series A | 8.3M |
10/2013 | Redbooth | Series A | 5M |
12/2015 | Enlibrium | Series A | 15M |
1/2011 | Aratana Therapeutics | Series A | 0 |
8/2005 | Intercasting | Series A | 5.5M |
3/2013 | Tapad | Series B | 6.5M |
5/2007 | Intercasting | Series B | 12M |
7/2013 | Conjur | Seed Round | - |
10/2009 | JustSpotted | Seed Round | 750k |
11/2012 | Kaltura | Series D | 25M |
6/2018 | Memrise | Series B | 15.5M |
4/2014 | Synthorx | Series A | 3.1M |
11/2013 | Sitari Pharmaceuticals | Series A | 10M |
9/2014 | Silarus Therapeutics | Series A | 10M |
2/2011 | RQx Pharmaceuticals | Series A | 7M |
2/2011 | MOGL | Series A | 2.4M |
6/2015 | Cadherx Therapeutics | Series A | 10M |
12/2012 | Avelas Biosciences | Series A | 7.7M |
3/2008 | Chumby | Series B | 12.5M |
7/2012 | Kinvey | Series A | 5M |
11/2007 | AnaptysBio | Series B | 0 |
4/2012 | Simulmedia | Series C | 6M |
6/2015 | Indix | Series B | 15M |
7/2008 | Zynga | Series B | 25M |
11/2022 | Jnana Therapeutics | Series C | 0 |
5/2015 | BookBub | Series B | 7M |
2/2007 | Inogen | Series D | 22M |
6/2019 | Simulmedia | Series E | 29M |
8/2015 | Empyr | Venture Round | 7.9M |
9/2018 | Joy | Series A | 0 |
6/2014 | Tapad | Series B | 0 |
3/2020 | Orion Labs | Series B | 0 |
2/2014 | Sidecar Technologies | Series B | 10M |
1/2008 | Zynga | Series A | 0 |
2/2008 | Zynga | Series A | 5M |
3/2009 | Simulmedia | Series A | 4M |
5/2011 | Simulmedia | Series C | 9.3M |
4/2010 | Simulmedia | Series B | 8M |
10/2022 | Enlaza Therapeutics | Seed Round | 61M |
7/2016 | Synthorx | Series B | 10M |
4/2021 | Janux Therapeutics | Series B | 0 |
2/2014 | MOGL | Series B | 10.5M |
12/2011 | Aratana Therapeutics | Series B | 15M |
4/2007 | Syndax Pharmaceuticals | Series A | 40M |
3/2010 | Syndax Pharmaceuticals | Series A | 9M |
12/2017 | Jnana Therapeutics | Series A | 50M |
2/2011 | Empyr | Series A | 2.4M |
1/2012 | Empyr | Series B | 12M |
4/2014 | Otonomy | Series D | 49M |
7/2019 | Node | Venture Round | 0 |
8/2005 | Amira Pharmaceuticals | Series A | 3M |
9/2011 | Techstars | Venture Round | 24M |
4/2015 | ScoreStream | Seed Round | 3M |
6/2016 | Node | Seed Round | 7.5M |
12/2014 | Conjur | Venture Round | 2.6M |
5/2013 | Cloudant | Series B | 12M |
4/2010 | RethinkDB | Seed Round | 1.2M |
9/2016 | Fortis Therapeutics | Series A | 18M |
3/2021 | Fortis Therapeutics | Series A | 0 |
3/2010 | Ad Summos | Venture Round | 3M |
6/2007 | Ortiva Wireless | Series B | 15M |
9/2009 | Cloudkick | Seed Round | 750k |
12/2006 | Chumby | Series A | 5M |
3/2015 | Nanigans | Series B | 24M |
12/2008 | Cloudant | Series A | 1M |
2/2017 | Piper Networks | Venture Round | 5.8M |
2/1999 | TomoTherapy | Series A | 3M |
2/2015 | Overlap.cc | Pre Seed Round | - |
9/2010 | Backupify | Series A | 4.5M |
5/2018 | BotChain | Venture Round | 5M |
1/2014 | Chartio | Venture Round | 2.2M |
9/2021 | Joy | Series A | 0 |
4/2017 | NanoNets | Seed Round | 1.4M |
11/2008 | Zacharon Pharmaceuticals | Series A | 3.5M |
3/2007 | Amira Pharmaceuticals | Series B | 25M |
4/2013 | Nanigans | Series A | 5.8M |
1/2012 | MOGL | Series B | 12M |
7/2016 | AristaMD | Series A | 11M |
9/2021 | Joy | Series A | 0 |
8/2021 | Jnana Therapeutics | Series B | 0 |
6/2021 | Primer | Series C | 0 |
4/2021 | Janux Therapeutics | Series B | 0 |
3/2021 | Fortis Therapeutics | Series A | 0 |
3/2021 | Janux Therapeutics | Series A | 0 |
6/2020 | Pando | Series A | 0 |
4/2020 | Figg | Funding Round | - |
3/2020 | AristaMD | Series B | 0 |
3/2020 | Orion Labs | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|